ADVANTAGE INVESTMENT MANAGEMENT, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.

Quarter-by-quarter ownership
ADVANTAGE INVESTMENT MANAGEMENT, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2019$6,000
-33.3%
1,5000.0%0.01%
-28.6%
Q2 2019$9,000
+50.0%
1,5000.0%0.01%
+40.0%
Q1 2019$6,000
+100.0%
1,5000.0%0.01%
+150.0%
Q4 2018$3,0001,500
+1400.0%
0.00%
Q1 2018$01000.0%0.00%
Q4 2017$0
-100.0%
1000.0%0.00%
Q3 2017$1,0000.0%100
-50.0%
0.00%
Q2 2017$1,0000.0%2000.0%0.00%
Q1 2017$1,000
-75.0%
200
-72.4%
0.00%
-100.0%
Q4 2016$4,000
+300.0%
724
+262.0%
0.00%
Q3 2016$1,0000.0%2000.0%0.00%
Q2 2016$1,0000.0%2000.0%0.00%
Q1 2016$1,000
-80.0%
200
-66.7%
0.00%
-100.0%
Q4 2015$5,000
+150.0%
600
+177.8%
0.00%
+200.0%
Q3 2015$2,000216
+575.0%
0.00%
Q2 2015$0
-100.0%
32
-89.8%
0.00%
-100.0%
Q1 2015$3,0000.0%315
-37.0%
0.00%0.0%
Q4 2014$3,0005000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2015
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders